Mecamylamine for Autonomic Dysreflexia Prophylaxis
Public ClinicalTrials.gov record NCT03914677. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Pilot Study of Mecamylamine for Autonomic Dysreflexia Prophylaxis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a preliminary study of the antihypertensive drug mecamylamine, used in the specific circumstance of hypertension caused by autonomic dysreflexia (AD), a condition that affects people with spinal cord injury (SCI). Initially, mild sensory stimulation of subjects' legs is used to intentionally provoke AD, as reflected by blood pressure elevation during such stimulation. In subsequent testing sessions, mecamylamine is given prior to sensory stimulation, to show the effect of the drug on preventing these AD-related blood pressure elevations.
Study identification
- NCT ID
- NCT03914677
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 5 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 12, 2019
- Primary completion
- Mar 16, 2020
- Completion
- Dec 30, 2020
- Last update posted
- Oct 6, 2019
2019 – 2020
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Wayne State University | Detroit | Michigan | 48201 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Spinal Cord Injuries trials
Other public records listing Spinal Cord Injuries. Sorted by last update posted; newest first. Not a recommendation.
- NCT07792616: Electrical Neuromodulation for Modifying Spinal Network Involved in Spasticity Active, not recruiting
- NCT07742553: Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial Not yet recruiting
- NCT05589415: Targeted HD-tDCS to Improve Upper Limb Rehabilitation in SCI Active, not recruiting
- NCT07222046: Spinal Neurorehabilitation for Veterans With SCI Not yet recruiting
- NCT00623389: Evaluation of an Advanced Lower Extremity Neuroprostheses Recruiting
- NCT05321017: Wrist Extensor MEP Up-conditioning for Individuals With Incomplete Spinal Cord Injury Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03914677, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 6, 2019 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03914677 live on ClinicalTrials.gov.